A new report from Reportlinker, "Infection Control Market [Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience)]: Global Forecast to 2021," indicates that the global infection control market is expected to grow at a CAGR of 6.5 percent during the forecast period of 2016 to 2021. The market is poised to reach $17.78 billion by 2021 from $13 billion in 2016. The market is primarily driven by growth in the number of surgical procedures, growing aging population, rising incidence of hospital acquired infections (HAIs), and rising focus on the need of food sterilization and disinfection.
In 2015, the disinfection products accounted for the largest share of the infection control market, the report says, adding that this share of the disinfection market can be attributed to the large-scale use of disinfectors and medical nonwovens in the healthcare industry. However, the sterilization products market is expected to grow at a higher CAGR during the forecast period due to growing emphasis on infection control policies within hospital premises and strengthening of government regulations for quality of healthcare services delivered.
In 2015, North America accounted for the largest share of the global infection control market, followed by Europe, Asia-Pacific, Latin America, and Middle East and Africa. Asia-Pacific is expected to be the fastest-growing region during the forecast period, due to rising incidences of HAIs and increasing medical tourism in emerging countries such as China and India.
Some of the key players operating in this market include Getinge Group (Sweden), Advanced Sterilization Products (U.S.), STERIS Corporation (U.S.), 3M Company (U.S.), Belimed AG (Switzerland), Halyard Health, Inc. (U.S.), Sterigenics International, Inc. (U.S.), MMM Group (Germany), Cantel Medical Corporation (U.S.), and Matachana Group (Spain).